Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
SWOG Cancer Research Network
Status
Recruiting
NCT ID
NCT03418961
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Intervention
Carvedilol, Laboratory Biomarker Analysis, Patient Observation
Condition
Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
Investigators
Justin Floyd, Ashkan Bahrani, Shelly S. Lo, Bryan A. Faller, Erin F. Cobain, Sunitha Vemulapalli, Jay W. Carlson, Cynthia M. Vakhariya, Kathleen J. Yost, Sailendra Vasireddy, Sung Ho B. Lee, Richard L. Deming, Barbara S. Craft, Halle C. Moore, David M. King, Hadeel Assad, Joanne E. Mortimer, Gregory A. Masters, Martine Extermann, Abdul Hai Mansoor, Anne P. O'Dea, Charles H. Nash, John M. Schallenkamp, Gina G. Chung, Thomas E. Lad, Jacklyn M. Nemunaitis, Naveed A. Rana, Bonni L. Guerin, Rachel L. Yung, Lisa Bailey, Josh D. Simmons, Yadyra Rivera, Kathryn M. Leininger, Ki Y. Chung, Charles W. Drescher, Priya Jayachandran, Alison E. Spellman, Marshall P. Stagg, Tareq Al Baghdadi, Haythem Y. Ali, Dan Costin, Bahar Moftakhar, Mahmoud Charif, Alexandra d. Zimmer, Monali K. Vasekar, Joyson Poulose, Vlad G. Zaha, Robert M. Kyler, Victor T. Lin, Site Public Contact, Keun Seok Lee, Amelia B. Zelnak, Andrew Piper-Vallillo, Iftekhar A. Khan, Shahzad Siddique, Kevin M. Kalinsky, Danish Safi
CT Research Area
Symptom Science

See list of participating sites